Skip to main content
. Author manuscript; available in PMC: 2012 Sep 16.
Published in final edited form as: Vaccine. 2011 Jul 23;29(40):6994–7001. doi: 10.1016/j.vaccine.2011.07.035

Figure 2.

Figure 2

Figure 2

a-c: Comparison of geometric mean antibody concentrations at baseline and one- and six months after three doses of pneumococcal conjugate vaccine (PCV) for colonized versus not colonized with serotype 19F prior to first dose of PCV.

d-f: Comparison of geometric mean antibody concentrations at baseline and one- and six months after three doses of pneumococcal conjugate vaccine (PCV) for infants colonized with serotype 19F only prior to the second and/or third dose of PCV versus those not colonized until the third PCV dose.